Search results
“Monstrous” Discovery: Scientists Identify Key to Stopping Cancer Recurrence
SciTechDaily· 3 days agoScientists have discovered that polyploid giant cancer cells, which are monstrously oversized and...
Theralase(R) Successfully Destroys Lung Cancer
Digital Journal· 12 hours agoIn this model, mouse lungs are subjected to lung cancer cells, which induces these mice to develop very aggressive, fast growing and metastatic lung tumours.
Breast cancer: New blood test can predict return, researchers say
BBC News· 4 days agoAn "ultra-sensitive" new blood test can predict if breast cancer will return years before the...
Calgary Prostate Cancer Support Group: Meeting For Patients & Partners Announced
Digital Journal· 2 days agoPRESS RELEASE Published June 4, 2024 AmpWire The gatherings provide a space for members to share their experiences of prostate cancer, discuss the physical ...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 2 days agoFPI-2265 is a promising new treatment for patients with metastatic castration-resistant prostate ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 7 days agoWhat will it treat? PCNA is found in all cancers, and AOH1996 has shown promise in 70 cell lines,...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 2 days agoThe two companies are launching a larger trial of the same approach in melanoma and are also testing...
Michael Richards discusses 'Seinfeld,' the 'Curb' finale and the incident that changed his life
NBC New York· 6 hours agoA door opens and Michael Richards makes his entrance. At 74 years old, his persona is far different...
Gamechanging blood test predicts breast cancer relapse up to three years early
Daily Express· 5 days agoAn “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before...
Nucleus RadioPharma secures Series A investment from AstraZeneca
BioPharma-Reporter· 13 hours agoThe investment from AstraZeneca marks a strategic move to further expand Nucleus's capabilities in developing targeted radiotherapies and theranostics, aimed at making cancer
